Oxycodone

Ibogaine By David Dardashti Analyzes Connections Between Physical and Emotional Pain

Retrieved on: 
Monday, January 15, 2024
Hydrocodone, Oxycodone, Fentanyl, Physical fitness, Communication, Opioid, Chronic pain, Ibogaine, Pain, Methadone, Buprenorphine/naloxone, Research, Brain, Nursing

While opiates are commonly used to treat physical pain, they have been found to have a significant impact on emotional pain as well.

Key Points: 
  • While opiates are commonly used to treat physical pain, they have been found to have a significant impact on emotional pain as well.
  • Research suggests that opiates enhance the production of opiate receptors, creating interconnected pathways that regulate both physical and emotional pain.
  • These drugs create interconnected pathways that regulate both emotional and physical pain, providing relief to individuals struggling with opioid addiction.
  • This not only helps individuals recover without having to undergo physical and emotional discomfort, but also stabilizes the brain and body, improving communication between physical and emotional pain.

NarcX+ First to Meet DEA Standards for Destroying Illicit Fentanyl and Rendering It Non-Retrievable

Retrieved on: 
Tuesday, January 16, 2024
Public Policy, Government, Pharmaceutical, Medical Supplies, Health, Law Enforcement, Emergency Services, Hospitals, Public Safety, Other Health, Powder, Forensic science, Oxycodone, DEA, Forensic toxicology, LCMS, Heroin, CBD, Tablet, Prohibition, Law enforcement, THC, Cocaine, Adderall, Drug

NarcX+ has successfully completed the first independent validation, by a 3rd party criminal laboratory, of its kind by testing its effectiveness against illicit fentanyl tablets and powders.

Key Points: 
  • NarcX+ has successfully completed the first independent validation, by a 3rd party criminal laboratory, of its kind by testing its effectiveness against illicit fentanyl tablets and powders.
  • The environmentally safe solution, NarcX+, has been analytically tested using LCMS technology, and proven that after a short amount of time the illicit fentanyl drug is non-detectable and non-retrievable meeting all DEA standards.
  • The Center for Forensic Science Research & Education (CFSRE), a forensic toxicology and chemistry laboratory, conducted a series of analytical tests by adding illicit fentanyl to NarcX+.
  • The tests conducted validate that at 5 minutes illicit fentanyl tablets are completely destroyed and non-retrievable.

Harvard MedTech Celebrates 2023 Comp Laude® Injured Worker Honoree Ronan McEvoy

Retrieved on: 
Thursday, November 16, 2023
Wearables, Mobile Technology, Technology, Mental Health, Medical Devices, Neurology, Health Technology, Telemedicine, Virtual Medicine, Physical Therapy, Health, Harvard University, Human, Back injury, Sleep, Brain, Depression, Post-traumatic stress disorder, Award, Pain management, Patient, Virtual reality, Mevalonate pathway, Oxycodone, Anxiety, Comp, Trauma, PTSD, Pain, Laminectomy, Electricity, Sciatic nerve, Quality of life, Rónán, Thought

The 2023 Comp Laude® Awards has selected Harvard MedTech patient Ronan McEvoy as an Injured Worker Honoree, as announced Tuesday in a virtual ceremony.

Key Points: 
  • The 2023 Comp Laude® Awards has selected Harvard MedTech patient Ronan McEvoy as an Injured Worker Honoree, as announced Tuesday in a virtual ceremony.
  • Ronan McEvoy was working as a successful restaurant manager when he suffered a serious back injury after moving a heavy object.
  • As a result, he relied on 10mg doses of Oxycodone up to three to four times a day to manage his pain.
  • It wasn’t until his neurosurgeon recommended Vx® Therapy, offered by Harvard MedTech, that he finally found relief.

Holiday Pet Dangers

Retrieved on: 
Wednesday, November 15, 2023
CNS, Xanthine, Holiday, Vomiting, Poisoning, Pet, Urine, Blood pressure, Cat, Toxicity, THC, Toxicology, Coma, Risk, Tremor, Arrhythmia, Chocolate, Hypoglycemia, Xylitol, Metabolic acidosis, Ataxia, New Year's Eve, Milk, Heart rate, Animal, Acute liver failure, Oxycodone, Ethanol, Hypoventilation, Friends, Alaskan Malamute, Caffeine, Seizure, Golden, Kidney failure, Diarrhea, Survival, Death, Tachycardia, Happiness, Paracetamol, Classic, Family, Nightmare, Mouth, Sodium chloride, Central nervous system, Failure, Common, Dog, Hypothermia, Lethargy, Radar, Theobromine, Fireworks, Liquor, Tourism, Makita

MINNEAPOLIS, Nov. 15, 2023 /PRNewswire/ -- The holidays are best spent with family and friends, not taking a trip to the animal hospital. With the trifecta of Thanksgiving, Christmas and New Years Eve coming up, the toxicology experts at Pet Poison Helpline want to warn pet lovers about the many dangers that face pets during this festive season.

Key Points: 
  • With the trifecta of Thanksgiving, Christmas and New Years Eve coming up, the toxicology experts at Pet Poison Helpline want to warn pet lovers about the many dangers that face pets during this festive season.
  • Meinke also contacted Pet Poison Helpline, who then worked with the medical team at BluePearl to identify the lily, diagnose and treat his pets.
  • "Many holiday treats include chocolate, and are often left sitting out on counters and dinner tables," said Dr. Schmid.
  • This year, we want pet lovers to remember the holidays for all the joy and happiness, not an emergency room visit."

PRISCILLA PRESLEY HONORED AT VICTORIA'S VOICE FOUNDATION MUSIC FOR LIFE GALA HEADLINED BY "GODMOTHER OF SOUL" PATTI LABELLE

Retrieved on: 
Tuesday, November 14, 2023
Naloxone, Courage, Human, Fentanyl, Business development, Food, Human voice, Victoria's Voice Foundation 200, Drug overdose, Music, Legacy Award, Dance, Death, Oxycodone, Fear, Heroin, ONDCP, CDC, DEA, ILG, Inc., Serious Request, Consciousness, Cereal, Auction

ORLANDO, Fla., Nov. 14, 2023 /PRNewswire/ -- Priscilla Presley was honored at Victoria's Voice Foundation gala "Music for Life" on November 11, receiving the 2023 Legacy Award for her courage and grace amidst adversity. Presley, a best-selling author, actress and executive producer of the critically acclaimed feature film, "Priscilla," received the award in front of nearly 300 attendees from Jackie Siegel, the co-founder of Victoria's Voice.

Key Points: 
  • Special Evening in Palm Island, Florida Raised Funds to Fight Opioid Crisis
    ORLANDO, Fla., Nov. 14, 2023 /PRNewswire/ -- Priscilla Presley was honored at Victoria's Voice Foundation gala "Music for Life" on November 11, receiving the 2023 Legacy Award for her courage and grace amidst adversity.
  • Presley, a best-selling author, actress and executive producer of the critically acclaimed feature film, "Priscilla," received the award in front of nearly 300 attendees from Jackie Siegel, the co-founder of Victoria's Voice.
  • Victoria's Voice provides drug prevention education and naloxone awareness, support and resources to those affected by substance use.
  • For photos from the Music for Life Gala, click here .

Fentanyl.org Launches Platform Providing Real Time Help - Get Reliable Information About Fentanyl & Synthetic Opioids Comprehensive Directory of Treatment & Opiate Detox Options

Retrieved on: 
Wednesday, November 8, 2023
Opioid, Parent, Morphine, DEA, Heroin, Skin, Death, Oxycodone, Drug, Fentanyl, Adderall

COMMACK, N.Y., Nov. 8, 2023 /PRNewswire/ -- Fentanyl kills more people in the USA than have died in wars. It is so deadly that even inhaling it can cause death First responders have died from coming into contact with it, as it is easily absorbed through the skin. Fentanyl comes into the USA from the land, sea and air borders. The nations youth are dying in record numbers from Fentanyl Laced counterfeit street drugs.

Key Points: 
  • Over 300 Americans die every day from overdoses related to synthetic opioids like fentanyl.
  • Fentanyl is a synthetic opioid that is up to 50X stronger than heroin and 100X stronger than morphine.
  • Fentanyl is commonly used to create counterfeit drugs sold on the street as OxyContin, Xanax, Adderall, and other pills.
  • In 2022, the DEA seized more than 58.3 million pills containing fentanyl and more than 13,000 pounds of fentanyl powder.

The roots of the North American opioid crisis, and 3 key strategies for stopping it

Retrieved on: 
Tuesday, October 17, 2023
Pain, Purdue University, Heroin, Oxycodone, Industry, Cocaine, Opioid use disorder, Research, Public, Morphine, Government, United Kingdom, Benzodiazepine, Fentanyl, Social support, Methadone, Office of National Drug Control Policy, Employment, Death, Psychotherapy, Medicine, FDA, Netflix, Education, Purdue Pharma, Prescription, Marketing, Awareness, United States drug overdose death rates and totals over time, Patient, Quality of life, Prison, Fatality, Video game, Pharmaceutical industry, Drug, Nursing, Analgesic

The Netflix series Painkiller recently depicted how the over-prescribing of the medicine OxyContin wreaked havoc on American society.

Key Points: 
  • The Netflix series Painkiller recently depicted how the over-prescribing of the medicine OxyContin wreaked havoc on American society.
  • Today the grim reality is that opioid-related deaths in North America reached a record level in 2022, with more than 109,000 fatalities in the United States.
  • The opioid overdose crisis has been ongoing for over two decades in Canada and the U.S.

The roots of the crisis

    • After introduction of the opioid painkiller OxyContin in 1996, Purdue Pharma marketed the drug aggressively, underplaying its potential for addiction.
    • To address addiction, prescription monitoring programs aimed to limit supply but many patients then sought illicit opioids, leading to large heroin markets in the 2010s.
    • Fentanyl is extremely toxic — up to 100 times stronger than heroin — and is largely responsible for the increase in overdose deaths.

1. Treat substance use disorders as a public health problem

    • In reality the data shows that illegal drug prices have fallen whilst purity and deaths have increased.
    • Overdose deaths have also increased in prisons showing that places with even the highest level of security are vulnerable to drug smuggling.
    • Focusing on the opioid crisis through a public-health approach includes massively increasing access to care and treatment for patients experiencing substance use disorder.

2. Find better treatments through research

    • Although these are effective when used, there are barriers to access and long-term engagement with these treatments.
    • We need more innovation to rapidly increase access to care and to find better therapies that suit the needs of different patients.
    • These research initiatives aim to increase the number of evidence-based treatments that can be used to enhance patient recovery and quality of life.

3. Stop the international spread of the epidemic

    • Currently the epidemic is contained within North America but there is the real concern of the crisis spreading to other countries.
    • Clinicians must remain actively vigilant on how they prescribe these drugs.
    • There should be greater international regulation in the marketing and operational strategies of pharmaceuticals, and oversight of the “revolving door” between industry and regulator employment.
    • There is a potential conflict of interest when pharma companies hire the government employees who oversee their applications.

KVK-Tech, Inc. Issues Voluntary Nationwide Recall of one lot of Betaxolol Tablets, USP 10 mg (Batch Number: 17853A) as a precautionary measure due to a single foreign tablet found during the line clearance after the batch was packaged

Retrieved on: 
Friday, September 29, 2023
Online, Heart, Letter, Completeness, Pharmacy, FedEx, Betaxolol, Oxycodone, Opioid use disorder, Tablet, EST, OUD, Multimedia, USP, KVK, Patient, Risk, Hypoventilation, Knowledge, Heart rate, FDA, HDPE, White, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Dietary supplement, Online shopping

The batch is being recalled as a precautionary measure due to a single Oxycodone HCl tablet 5 mg foreign tablet found on the packaging line during the line clearance after the subject batch was packaged.

Key Points: 
  • The batch is being recalled as a precautionary measure due to a single Oxycodone HCl tablet 5 mg foreign tablet found on the packaging line during the line clearance after the subject batch was packaged.
  • KVK has not received any reports of foreign tablet in any bottle of Betaxolol Tablets, USP 10 mg (Batch Number 17853A) at this time.
  • Additionally, some patients prescribed low-dose betaxolol might have compromised heart and lung function that is also likely to be exacerbated by an opioid.
  • Furthermore, there are minor differences in appearance between betaxolol 10 mg tablets and oxycodone 5 mg tablets, not likely to be noticed by a regular user of the 10 mg betaxolol tablet.

Lifshitz Law PLLC Announces Investigations of Stanley Black & Decker, Inc. (NYSE: SWK), Dish Network Corp (NASDAQ: DISH), Rite Aid Corp (NYSE: RAD), and United Natural Foods, Inc. (NYSE: UNFI)

Retrieved on: 
Sunday, September 10, 2023
Data management, Controlled Substances Act, SWK, Stanley, Justice, RAD, Information technology, Rite Aid, Telephone, DISH, UNFI, Oxycodone, United States Department of Justice, COVID-19, Ground substance, Prescription, False Claims Act, Complaint, Pharmacist, United Natural Foods, Advertising, Risk, Fentanyl, Hewlett, Online shopping

If you are a DISH investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.

Key Points: 
  • If you are a DISH investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties.
  • Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties.
  • The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780.

Sorrento Therapeutics Announces Positive Phase 2a Clinical Trial Results for Resiniferatoxin (RTX) for the Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients

Retrieved on: 
Thursday, September 7, 2023
HTN, AE, Lidocaine, OAK, Oxycodone, Aes, Clinical trial, ECG, Capsaicin, Bankruptcy, Female, Pain, Hypertension, SPID, SAE, Patient, Standard of care, WOMAC, KOOS, SAN, OTC, Hydromorphone, BMI, FDA, Therapy, Triamcinolone acetonide, RTX, Safety, Pharmaceutical industry, Birth control

RTX 20mcg and 12.5mcg have been selected as the clinically optimal and minimally effective doses for further phase 2 pivotal or phase 3 trials.

Key Points: 
  • RTX 20mcg and 12.5mcg have been selected as the clinically optimal and minimally effective doses for further phase 2 pivotal or phase 3 trials.
  • SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento") announced today positive Phase 2a top-line clinical trial results for the RTX program.
  • A higher proportion of patients responded to treatment with RTX 20mcg than any other treatment group, including Zilretta.
  • The clinical trial confirmed the potential of resiniferatoxin (RTX) in helping patients with moderate to severe osteoarthritis pain for at least 6 months, if not longer.